Han-Ting Lin, MD
Hematology & Oncology Physician · Salem, NH
Han-Ting Lin, MD is a hematology & oncology physician with a practice address in Salem, New Hampshire, and NPI 1114019148, issued on Sep 28, 2006. Check the license (New Hampshire 10954, as entered in NPPES) on the New Hampshire Board of Medicine; the Medicare figures below come from public CMS files.
- Name
- Han-Ting Lin
- Credential
- MD
- Primary taxonomy
- Hematology & Oncology Physician 207RH0003X
- License numbers
- 10954 NH
159178 MA
Self-reported in NPPES; status is on the state search - Practice location
- 31 Stiles RD Ste 2400, Salem, NH 03079
- Phone
- (603) 890-2750
- Enumerated
- Sep 28, 2006
- Record last updated
- Dec 30, 2022
- Fax
- (603) 890-2752
- Medicaid ID
- 2018624 MA
- Medicare enrollment
- Enrolled (PECOS I20090429000632); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
8 nearest hematology & oncology physician records → All 76 in New Hampshire → Look up another NPI →
Also registered at 31 Stiles RD Ste 2400
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Ana Stankovic, MD FACP FASN FASHNephrology Physician1992794515
Verify Han-Ting Lin in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersNew Hampshire Board of Medicine
Search for license 10954Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
17% more Medicare Part D claims than the average hematology & oncology physician in 2024
1,023 Medicare Part D claims for 170 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. 74 claims were for opioids.
Most prescribed
- Hydroxyurea74 claims
- Prednisone60 claims
- Letrozole59 claims
- Acyclovir53 claims
- Sulfamethoxazole-Trimethoprim50 claims
- Lenalidomide48 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $42.62
2 payments; by number, the most common kind was education; the largest payer was E.R. Squibb & Sons, L.L.C. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Atrius Health IncDedham, MA
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Han-Ting Lin among 76 hematology & oncology physician records in New Hampshire
Han-Ting Lin, MD is one of 76 hematology & oncology physician records with a practice address in New Hampshire. 87% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2006, is newer than 12% of them.
- NPI issued2006 · 12% of these records are older, 45% newer
- In a Medicare fileYes · 87% of these records are
- In the CMS Doctors and Clinicians fileYes · 70% of these records are
- Graduated1983 · median 2001 among the 53 with a school on file
- Record last updated2022 · 58% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RH0003X and a New Hampshire practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Hematology & Oncology Physician providers in New Hampshire
There are 76 hematology & oncology physician records in New Hampshire.
All 76 in New Hampshire → Every provider in Salem → Hematology & Oncology Physician nationwide →
The 8 hematology & oncology physician records with the nearest ZIP codes
- Ananta Bhatt, M.D.Nashua, NH 030631295025435
- Nancy Chun, MDNashua, NH 030601356302822
- Abdel Hosein, M.D., PH.D.Nashua, NH 030601538574892
- Yugandhara Kate, MDNashua, NH 030601528544236
- Timothy Marquis, MDNashua, NH 030601093334872
- Gautami Rao, M.D.,Nashua, NH 030601497862569
- Mary Voltz, M.D.Nashua, NH 030601578540670
- Hassan Yameen, M.D.Nashua, NH 030601922350883
Common questions
What is Han-Ting Lin, MD's NPI number?
Han-Ting Lin, MD's National Provider Identifier (NPI) is 1114019148, issued on Sep 28, 2006. An NPI identifies a provider in billing; it is not a license.
Where is Han-Ting Lin, MD located?
The NPPES record lists a practice address at 31 Stiles RD Ste 2400, Salem, NH, 03079. Phone: (603) 890-2750. Providers update this record themselves, so call before visiting.
How can I verify Han-Ting Lin, MD's license?
NPPES lists New Hampshire license number 10954, as entered by the provider. Search the New Hampshire Board of Medicine at https://www.oplc.nh.gov/board-medicine. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Han-Ting Lin, MD prescribe under Medicare Part D?
In 2024, Han-Ting Lin, MD had 1,023 Medicare Part D claims for 170 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.